Brinker Capital Investments’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-1,390
| Closed | -$257K | – | 1898 |
|
|
2024
Q4 | $257K | Sell |
1,390
-1,847
| -57% | -$341K | ﹤0.01% | 1629 |
|
|
2024
Q3 | $638K | Sell |
3,237
-67
| -2% | -$13.2K | 0.01% | 1243 |
|
|
2024
Q2 | $683K | Sell |
3,304
-74
| -2% | -$15.3K | 0.01% | 1163 |
|
|
2024
Q1 | $915K | Sell |
3,378
-38
| -1% | -$10.3K | 0.01% | 1026 |
|
|
2023
Q4 | $775K | Sell |
3,416
-602
| -15% | -$137K | 0.01% | 1049 |
|
|
2023
Q3 | $787K | Sell |
4,018
-560
| -12% | -$110K | 0.01% | 1032 |
|
|
2023
Q2 | $963K | Sell |
4,578
-107
| -2% | -$22.5K | 0.01% | 970 |
|
|
2023
Q1 | $946K | Sell |
4,685
-474
| -9% | -$95.7K | 0.01% | 899 |
|
|
2022
Q4 | $1.12M | Sell |
5,159
-269
| -5% | -$58.6K | 0.02% | 695 |
|
|
2022
Q3 | $1.07M | Buy |
5,428
+149
| +3% | +$29.3K | 0.02% | 682 |
|
|
2022
Q2 | $1.13M | Sell |
5,279
-632
| -11% | -$135K | 0.02% | 689 |
|
|
2022
Q1 | $1.68M | Sell |
5,911
-261
| -4% | -$74.1K | 0.03% | 597 |
|
|
2021
Q4 | $2.33M | Buy |
6,172
+1,041
| +20% | +$392K | 0.03% | 514 |
|
|
2021
Q3 | $1.9M | Hold |
5,131
| – | – | 0.03% | 560 |
|
|
2021
Q2 | $1.9M | Sell |
5,131
-525
| -9% | -$194K | 0.03% | 613 |
|
|
2021
Q1 | $1.64M | Sell |
5,656
-1,828
| -24% | -$530K | 0.02% | 567 |
|
|
2020
Q4 | $1.87M | Buy |
7,484
+3,379
| +82% | +$844K | 0.03% | 567 |
|
|
2020
Q3 | $930K | Buy |
+4,105
| New | +$930K | 0.02% | 708 |
|